Latest Articles
October 17, 2023
Understanding Gene-Disease Validity in Breast Cancer: The Power of Evidence
An overview of gene-disease validity in the context of breast cancer, which affects approximately 1 in every 8 women.
Breast Cancer
Breast Cancer Awareness
Clinical Research
Genetic Testing
Novel Genes
September 27, 2023
Ambry Spotlight: BRCAResponder Amy Byer Shainman
Amy Byer Shainman, BRCAResponder, is a patient advocate, author, and producer who provides support and education related to having a pathogenic variant in BRCA1/2. Hear…
BRCA
BRCA1 & 2
Breast Cancer Awareness
Genetic Testing
Patient Advocate
Previvor
September 20, 2023
Genetics in Medicine publication demonstrates a 10% lower rate of VUS with WES/WGS compared to panels
A discussion of VUS and explanation of their significance, highlighting Ambry’s collaboration in the GIM publication, The landscape of reported VUS in multi-gene panel and…
Clinical Research
Variant of Unknown Significance
September 14, 2023
Ovarian Cancer Awareness Month Spotlight: Norma Livingston Ovarian Cancer Foundation
The Norma Livingston Ovarian Cancer Foundation (NLOCF) was founded in Birmingham, Alabama in 2004. For Ovarian Cancer Awareness month, Ambry explores its history, spotlights campaigns…
Advocacy Group
Awareness
Genetic Counselors
Genetic Testing
Hereditary Cancer
Ovarian Cancer
August 9, 2023
Her Healthcare: Leveraging the CARE Program to Scale High-Risk Patient Identification
Dr. Boyd, patient Kristi and medical assistant Briana Guro give their thoughts on the implementation of The CARE Program in their practice.
Breast Cancer
Cancer Risk
Family History
OBGYN
August 2, 2023
Her Healthcare: Offering Comprehensive Care with Hereditary Cancer Testing
Dr. Noel Boyd from Her Healthcare in Houston, TX, explains the importance of genetic testing for hereditary cancer risk,
Breast Cancer
Colorectal Cancer
Genetic Testing
OBGYN
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)